Screening Low-Risk Individuals for Coronary Artery Disease
A large proportion of cardiovascular events occur in individuals classified by traditional risk factors as “low-risk.” Efforts to improve early detection of coronary artery disease among low-risk individuals, or to improve risk assessment, might be justified by this large population burden. The most promising tests for improving risk assessment, or early detection, include the coronary artery calcium (CAC) score, the ankle-brachial index (ABI), and the high-sensitivity C-reactive protein (hsCRP). Data regarding the role of additional testing in low-risk populations to improve early detection or to enhance risk assessment are sparse but suggest that CAC and ABI may be helpful for improving risk classification and detecting the higher-risk people from among those at lower risk. However, in the absence of clinical trials in this patient population, such as has recently been proposed, we do not recommend routine use of any additional testing or screening in low-risk individuals at this time.
KeywordsScreening Low-risk Asymptomatic Early detection
Compliance with Ethics Guidelines
Conflict of Interest
Chintan S. Desai, Roger S. Blumenthal, and Philip Greenland declare that they have no conflict of interest.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
- 7.Expert Panel on Detection E, Treatment of High Blood Cholesterol in A. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III). JAMA J Am Med Assoc. 2001;285(19):2486–97.CrossRefGoogle Scholar
- 9.Califf RM, Armstrong PW, Carver JR, D’Agostino RB, Strauss WE. 27th Bethesda Conference: matching the intensity of risk factor management with the hazard for coronary disease events. Task Force 5. Stratification of patients into high, medium and low risk subgroups for purposes of risk factor management. J Am Coll Cardiol. 1996;27(5):1007–19.PubMedCrossRefGoogle Scholar
- 12.Cooney MT, Dudina A, Whincup P, et al. Re-evaluating the Rose approach: comparative benefits of the population and high-risk preventive strategies. Eur J Cardiovasc Prev Rehabil Off J Eur Soc Cardiol Work Group Epidemiol Prev Card Rehabil Exerc Physiol. 2009;16(5):541–9.Google Scholar
- 14.••Greenland P, Alpert JS, Beller GA, et al. 2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2010;122(25):e584-636. This is an important review of all potential approaches to risk assessment in asymptomatic patients. It is a good source of detailed background on this subject. Google Scholar
- 15.••Anderson TJ, Gregoire J, Hegele RA, et al. 2012 update of the Canadian Cardiovascular Society guidelines for the diagnosis and treatment of dyslipidemia for the prevention of cardiovascular disease in the adult. Can J Cardiol. 2013;29(2):151–67. This update to previous Canadian Guidelines is an important reference source on the topics of prevention and risk assessment. Google Scholar
- 20.••Yousuf O, Mohanty BD, Martin SS, et al. High-sensitivity C-reactive protein and cardiovascular disease: a resolute belief or an elusive link? J Am Coll Cardiol. 2013;62(5):397–408. This is a comprehensive review of the utility of C-reactive protein for cardiovascular risk. It supports a limited role for hsCRP in risk assessment. Google Scholar
- 25.••Yeboah J, McClelland RL, Polonsky TS, et al. Comparison of novel risk markers for improvement in cardiovascular risk assessment in intermediate-risk individuals. JAMA J Am Med Assoc. 2012;308(8):788–95. This is one of a small number of analyses from a large cohort comparing risk assessment approaches using different tests. It supports a conclusion that CAC is the leading contender for improving risk assessment in intermediate risk populations. Google Scholar
- 27.••Kavousi M, Elias-Smale S, Rutten JH, et al. Evaluation of newer risk markers for coronary heart disease risk classification: a cohort study. Ann Intern Med. 2012;156(6):438–44. This paper is similar to reference 26 but applies across the entire Rotterdam cohort of mostly elderly men and women. Google Scholar
- 30.Desai CS, Ayers CR, Budoff M, et al. Improved coronary heart disease risk prediction with coronary artery calcium in low-risk women: a meta-analysis of four cohorts. J Am Coll Cardiol. 2013;61(10):E995–5.Google Scholar
- 34.•Ambrosius WT, Polonsky TS, Greenland P, et al. Design of the value of imaging in enhancing the wellness of your heart (VIEW) trial and the impact of uncertainty on power. Clin Trials. 2012;9(2):232–46. This is a provocative proposal for a large-scale trial of coronary artery calcium testing (screening) in asymptomatic low-risk individuals. It is an important “thought-piece” on this topic. Google Scholar